‘India not to stop hydroxychloroquine treatment in mild cases'
HCQ, currently used to treat lupus and rheumatoid arthritis, has split world opinion on its use in Covid-19 management, even as India said the decision was “taken based on risk-benefit assessment.”
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: Arthritis | COVID-19 | Health | Hydroxychloroquine | India Health | Lupus | Rheumatoid Arthritis | Rheumatology